National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Monica Livia Gheorghiu in
Google Scholar
PubMed
Search for other papers by Andrei Muresan in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Iuliana Gherlan in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
National Institute of Endocrinology CI Parhon, Bucharest, Romania
Search for other papers by Corin Badiu in
Google Scholar
PubMed
sweating, palpitations), life-threatening arrhythmia, stroke, or even death ( 1 ). Most PHEOs are rare sporadic unilateral adrenal tumors. However, 25–45% are hereditary ( 2 ). Bilateral PHEOs are very rare (7–10% of PHEOs); between 60% and 90% of the
Search for other papers by Natalie Rogowski-Lehmann in
Google Scholar
PubMed
Search for other papers by Aikaterini Geroula in
Google Scholar
PubMed
Search for other papers by Aleksander Prejbisz in
Google Scholar
PubMed
Search for other papers by Henri J L M Timmers in
Google Scholar
PubMed
Search for other papers by Felix Megerle in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Stephanie M J Fliedner in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Anthony Stell in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Jacques W M Lenders in
Google Scholar
PubMed
Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
affected by germline mutations of tumor-susceptibility genes that considerably increase the risk to develop additional PPGLs at new sites and other syndrome-related neoplasms ( 2 , 10 ). To date, at least 16 genes have been identified to be responsible for
Search for other papers by Carole Morin in
Google Scholar
PubMed
Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
Search for other papers by Agathe Deville in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Search for other papers by Laurent Milot in
Google Scholar
PubMed
Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France
Search for other papers by Mathieu Pioche in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Gilles Poncet in
Google Scholar
PubMed
Search for other papers by Julien Forestier in
Google Scholar
PubMed
Search for other papers by Laurent François in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Mustapha Adham in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
neuroendocrine carcinomas (NEC). To this end, the European Neuroendocrine Tumor Society (ENETS) has accredited 62 Centers of Excellence (CoE) around the world which aim to improve the diagnosis and therapy of patients with NEN in an international and
Search for other papers by Yiqiang Huang in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Qiubo Xie in
Google Scholar
PubMed
Search for other papers by Jian Pang in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Yuting Yi in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
Search for other papers by Yao Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
pediatric cases, 38% of malignant tumors and more than 80% of familial aggregations of PGL and PCC ( 14 ). Germline mutations in the SDHB gene are associated with hereditary paraganglioma syndrome type 4 (PGL4), while germline mutations of SDHD are
Search for other papers by M Ingenwerth in
Google Scholar
PubMed
Search for other papers by T Brandenburg in
Google Scholar
PubMed
Search for other papers by D Führer-Sakel in
Google Scholar
PubMed
Search for other papers by M Goetz in
Google Scholar
PubMed
Search for other papers by F Weber in
Google Scholar
PubMed
Search for other papers by H Dralle in
Google Scholar
PubMed
Search for other papers by H-U Schildhaus in
Google Scholar
PubMed
Search for other papers by K W Schmid in
Google Scholar
PubMed
Search for other papers by S Theurer in
Google Scholar
PubMed
thyroid cancer-associated deaths ( 1 , 2 ). They can occur either as part of hereditary syndromes (<30% of all MTC) in multiple endocrine neoplasias (MEN) 2A or 2B with germline mutations in the RET proto-oncogene or as sporadic tumors with approximately
Search for other papers by Malgorzata Oczko-Wojciechowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Tomasz Gawlik in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Jolanta Krajewska in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a rare, malignant neoplasm from the C-cell of the thyroid, which occurs in sporadic and hereditary forms. Hereditary MTC develops in the course of MEN2A and MEN2B syndromes due to germline
Search for other papers by Sara Lomelino Pinheiro in
Google Scholar
PubMed
Search for other papers by Ana Saramago in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Search for other papers by Carmo Martins in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Search for other papers by Tiago Nunes da Silva in
Google Scholar
PubMed
hereditary cancer syndrome and solid tumor-related genes were examined in the PC and PA DNAs (NGS multigene analysis: commercial TruSight Cancer panel, Illumina, CA, USA; custom designed panel of 113 genes, protocol Sureselect XT Target Enrichment System
Search for other papers by Felix Reschke in
Google Scholar
PubMed
Search for other papers by Torben Biester in
Google Scholar
PubMed
Search for other papers by Thekla von dem Berge in
Google Scholar
PubMed
Search for other papers by Dagmar Jamiolkowski in
Google Scholar
PubMed
Search for other papers by Laura Hasse in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Katharina Klee in
Google Scholar
PubMed
Search for other papers by Olga Kordonouri in
Google Scholar
PubMed
Search for other papers by Hagen Ott in
Google Scholar
PubMed
Search for other papers by Thomas Danne in
Google Scholar
PubMed
its rarity, makes the diagnosis particularly difficult ( 28 ). Alström syndrome Alström syndrome is a rare hereditary disease characterised by a variety of symptoms. These include, among others, photophobia and increasing blindness of the
Search for other papers by Catherine Cardot Bauters in
Google Scholar
PubMed
Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Search for other papers by Bruno Carnaille in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Stéphanie Espiard in
Google Scholar
PubMed
Search for other papers by Malo Penven in
Google Scholar
PubMed
Search for other papers by Evelyne Destailleur in
Google Scholar
PubMed
Search for other papers by Isabelle Szuster in
Google Scholar
PubMed
Search for other papers by Tonio Lovecchio in
Google Scholar
PubMed
CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France
Search for other papers by Julie Leclerc in
Google Scholar
PubMed
Search for other papers by Fredéric Frénois in
Google Scholar
PubMed
Search for other papers by Emmanuel Esquivel in
Google Scholar
PubMed
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Search for other papers by Emilie Ait-Yahya in
Google Scholar
PubMed
Search for other papers by Michel Crépin in
Google Scholar
PubMed
Search for other papers by Pascal Pigny in
Google Scholar
PubMed
halos differentiate hereditary leiomyomatosis and RCC-associated RCC from kidney tumors without FH gene alteration . Modern Pathology 2018 31 974 – 9 83 . ( https://doi.org/10.1038/s41379-018-0017-7 ) 18 Maiti R van Domselaar GH Zhang H
Search for other papers by Cristina Romei in
Google Scholar
PubMed
Search for other papers by Teresa Ramone in
Google Scholar
PubMed
Search for other papers by Chiara Mulè in
Google Scholar
PubMed
Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Search for other papers by Virginia Cappagli in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Raffaele Ciampi in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Introduction Medullary Thyroid Carcinoma (MTC) accounts for about 5–7% of all thyroid cancer and can occur in a hereditary (25%) or a sporadic form (75%) ( 1 ). According to the Next Generation Studies published in the last years ( 2 , 3